Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
06/2004
06/03/2004WO2004046137A1 New tricyclic angiotensin ii agonists
06/03/2004WO2004046130A1 Pyridazinone derivatives as cdk2-inhibitors
06/03/2004WO2004046119A1 Substituted aralkyl derivatives
06/03/2004WO2004046117A1 Pyridazinone derivatives as gsk-3beta inhibitors
06/03/2004WO2004046115A1 4-oxoquinoline compounds and utilization thereof as hiv integrase inhibitors
06/03/2004WO2004046095A1 Substituted aryl thioureas and related compounds; inhibitors of viral replication
06/03/2004WO2004037248A3 Modulation of peroxisome proliferator activated receptors activity
06/03/2004WO2004027046A3 Methods of producing 4-amino-3-mercapto-triazoles
06/03/2004WO2004022542A3 Substituted 1,2,3,4-tetrahydroquinoline derivatives
06/03/2004WO2004018419A3 Benzimidazole quinolinones and uses thereof
06/03/2004WO2004009549A3 Piperidines useful for the treatment of central nervous system disorders
06/03/2004WO2003051842A3 Compositions decreasing activity of hormone-sensitive lipase
06/03/2004US20040106805 optionally oxa-, thia- or hydrocarbylaza-substituted pentalenones, e.g., 3aR, 6aR) 4-tert-Butyl-N-[2-(4-hydroxyphenyl)-1S-(3-oxo-hexahydrocyclopenta[b]furan-3a-ylcChagas' diseasearbamoyl)-ethyl]benzamide; treating Chagas' disease
06/03/2004US20040106800 cannabinoid (cb1); treating disorders involving cannabinoid neurotransmission
06/03/2004US20040106794 3,4-Di-substituted cyclobutene-1,2-diones as CXC-chemokine receptor ligands
06/03/2004US20040106792 Biphenyl compound
06/03/2004US20040106676 Water-soluble etoposide analogs and methods of use thereof
06/03/2004US20040106667 novel specific indazoles exhibiting anticancer activity via the modulation of the activity of proteins, in particular of kinases
06/03/2004US20040106659 hydantoin, oxazoledione and thiazoledione (or dithiione) derivatives; e.g., 5-[1-(Biphenyl-4-yloxy)-ethyl]-5-methyl-imidazolidine-2,4-dione
06/03/2004US20040106645 Antagonists of melanin concentrating hormone receptor
06/03/2004US20040106634 Methods for treating or preventing an inflammatory or metabolic condition or inhibiting JNK
06/03/2004US20040106633 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors
06/03/2004US20040106627 Dihydroxypyrimidine carboxylic acids as viral polymerase inhibitors
06/03/2004US20040106626 amidine containing compounds which inhibit serine proteases
06/03/2004US20040106616 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
06/03/2004US20040106615 For treating or lessening the severity of a variety of disorders, including stroke, inflammatory disorders, autoimmune diseases such as SLE lupus and psoriasis, proliferative disorders such as cancer, and conditions associated with organ transplant
06/03/2004US20040106606 Dihydropyrones with tethered heterocycles
06/03/2004US20040106599 an aromatic or heteroaromatic amide compound useful as antiproliferative agent
06/03/2004US20040106521 Pyrrolecarboxamides and pyrrolethioamides as fungicides
06/03/2004US20040106519 Herbicidal composition
06/03/2004DE10254336A1 Carbonsäureamide Carboxamides
06/03/2004DE10254092A1 New pyrimidine-4,6-dicarboxamide derivatives, are selective collagenase inhibitors useful e.g. for treating degenerative joint diseases, connective tissue disorders or cancer
06/03/2004CA2518917A1 Pyridazinone derivatives as cdk2-inhibitors
06/03/2004CA2506415A1 Substituted aryl thioureas and releated compounds; inhibitors of viral replication
06/03/2004CA2506112A1 Substituted aralkyl derivatives
06/03/2004CA2506022A1 Pyridazinone derivatives as gsk-3beta inhibitors
06/02/2004EP1423393A1 Cyclic indole and heteroindole derivatives, the production and use thereof as medicaments
06/02/2004EP1423387A1 Photochromic bis-naphthopyran compounds and methods for their manufacture
06/02/2004EP1423386A1 Thiophenylthiopyrane dioxides as mmp or tnf-alpha inhibitors
06/02/2004EP1423381A1 17beta-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
06/02/2004EP1423366A1 Cyclopenta b ! indole derivatives as spla2 inhibitors
06/02/2004EP1423110A2 Cbi analogues of cc-1065 and the duocarmycins
06/02/2004EP1423100A1 Plaster for the treatment of dysfunctions and disorders of nails, comprising sertaconazole
06/02/2004EP1423004A1 Herbicidal n-alkylsulfonamino derivatives
06/02/2004CN1501917A Compounds useful as insecticides, compounds useful as acaricides, and processes to use and make same
06/02/2004CN1152032C Pyridyl alkene- and pyridyl alkine-acid amides as cytostatics and immunosuppressives
06/02/2004CN1152022C Alpha-substituted. pyrimidine-thioalkyl and alkyl ether compounds
06/02/2004CN1152020C Benzimidazolrone and analogues, and uses as progesterone ligand thereof
06/02/2004CN1152015C Piperazine devivatives and preparing method thereof
06/02/2004CN1152014C N-aryl anthranilic acid derivatives and uses thereof
06/02/2004CN1151789C Use of aryl (or heteroaryl) pyrrolyl methanol derivatives
06/01/2004US6743815 Estrogen receptor modulators
06/01/2004US6743810 Indol-3-yl derivatives
06/01/2004US6743809 Indole Derivatives useful for the treatment of CNS disorders
06/01/2004US6743808 4-aryl-1-(indanmethyl, dihydrobenzofuranmethyl or dihydrobenzothiophenemethyl) tetrahydropyridines or piperazines
06/01/2004US6743807 Cyclic β-amino acid derivatives as inhibitors of matrix metalloproteases and TNF-α
06/01/2004US6743804 Quinoline derivatives as NK3 antagonists
06/01/2004US6743793 Dp receptor antagonist; prostaglandin d
06/01/2004US6743788 Carbamate and oxamide compounds
05/2004
05/27/2004WO2004043983A1 4-methyl-2-oxo-2h-1-benzopyran-7yl 5-thio-beta-d-xylopyranoside derivative, method for preparing same and pharmaceutical composition containing same
05/27/2004WO2004043952A1 Novel 2,3-dihydro-4(1h)-pyridinone derivatives, method for production thereof and pharmaceutical composition comprising the same
05/27/2004WO2004043951A1 Pyrazole derivatives as modulators of peroxisome proliferator activated receptors
05/27/2004WO2004043950A1 Indolyl pyrazinone derivatives useful for treating hyper-proliferative disorders and diseases associated with angiogenesis
05/27/2004WO2004043948A1 Sulfonamides
05/27/2004WO2004043943A1 Aromatic sulfone hydroxamic acids and their use as protease inhibitors
05/27/2004WO2004043936A1 Plk inhibitors
05/27/2004WO2004043917A1 Sulfonamides
05/27/2004WO2004043463A2 Sulfonamides
05/27/2004WO2004043458A1 Bicyclic-substituted amines as histamine-3 receptor ligands
05/27/2004WO2004043389A2 Methods of treating cancer and related methods
05/27/2004WO2004043379A2 Chemical compounds
05/27/2004WO2004043368A2 Sulfonamides
05/27/2004WO2004043366A2 Sulfonamides
05/27/2004WO2004032908A9 Method of inhibiting angiogenesis
05/27/2004WO2003099812A8 Phenyl-furan or phenyl-thiophene derivatives, their preparation and their use as medicine
05/27/2004WO2003088908A3 Heterocyclo inhibitors of potassium channel function
05/27/2004WO2003039549A3 Selective antibacterial agents
05/27/2004WO2003031436A8 Heterocyclic compounds for use in the treatment of disorders of the urinary tract
05/27/2004WO2003024961A8 Insecticidal 3-(2,6-disubstituted phenyl)-5-[4- or 5-arylthien-2- or -3-yl]-1,2,4-triazoles
05/27/2004WO2003016276A3 3-substituted oxindole beta-3 agonists
05/27/2004US20040102633 For therapy and prophylaxis of chronic obstructive pulmonary disease (COPD), asthma, airway hyper- reactivity, cough; inflammatory diseases such as inflammatory bowel disease, psoriasis, fibrositis, osteoarthritis
05/27/2004US20040102630 For therapy of cancer, auto-immune diseases, cardiovascular diseases, infectious diseases, nephrological diseases, neurodegenerative diseases and viral infections
05/27/2004US20040102609 Peptide-containing alpha-ketoamide cysteine and serine protease inhibitors
05/27/2004US20040102592 As monomer to produce acrylic polymer
05/27/2004US20040102508 Naphathalene derivatives which bind to the ep4 receptor
05/27/2004US20040102507 Use of GALR3 receptor antagonists for the treatment of depression and/or anxiety and compounds useful in such methods
05/27/2004US20040102500 Peroxisome proliferator activated receptor alpha agonists
05/27/2004US20040102498 Estrogen receptor modulators
05/27/2004US20040102488 Antiinflamamtory agents; autoimmune diseases; antiarthritic agents; anticancer agents; Alzheimer's disease
05/27/2004US20040102484 Prodrugs of proton pump inhibitors
05/27/2004US20040102479 Novel benzopyran or thiobenzopyran derivatives
05/27/2004US20040102474 Dietetics; antidiabetic agents; eating disorders
05/27/2004US20040102464 Hypotensive agents; cardiovascular disorders; anticancer agents; headaches; antihistamines; antiinflamamtory agents
05/27/2004US20040102455 Autoimmune diseases; antiinflammatory agents; antiallergens; viricides; anticancer agents
05/27/2004US20040102450 Substituted oxoazaheterocyclyl compounds
05/27/2004US20040102449 Pyridinyl, pyrimidinyl and pyrazinyl amides as potassium channel openers
05/27/2004US20040102448 Substituted polycyclic aryl and heteroaryl pyrazinones useful for selective inhibition of the coagulation cascade
05/27/2004US20040102436 Heterocyclic compound derivatives and medicines
05/27/2004US20040102432 Asthma, rhinitis therapy
05/27/2004US20040102431 Protease inhibitors